Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Payment Type: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
(2R,3S)-2-{(1R)-1-[3,5-BI S(TRIFLUOROMETHYL)PHENYL]E THOXY}-3-(4-FLUOROPHENYL)M ORPHOLINE HCL, is an antiemetic drug developed by Merck in the United States to prevent acute and delayed vomiting during chemotherapy. Clinical studies have shown that when using moderate or highly emetic chemotherapeutics, adjuvant aprepit can significantly control the symptoms of nausea and vomiting (CINV) caused by chemotherapy. It can be used to treat depression and chemotherapy-induced vomiting intermediates.
Product Categories : API Intermediates > Intermediate for CAS 170729-80-3
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.